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http://www.biomedcentral.com/1471-2121/14/3RESEARCH ARTICLE Open AccessmTOR direct interactions with Rheb-GTPase and
raptor: sub-cellular localization using fluorescence
lifetime imaging
Rahul B Yadav1, Pierre Burgos1, Anthony W Parker1, Valentina Iadevaia2, Christopher G Proud2, Rodger A Allen3,
James P O'Connell3, Ananya Jeshtadi4, Christopher D Stubbs1* and Stanley W Botchway1*Abstract
Background: The mammalian target of rapamycin (mTOR) signalling pathway has a key role in cellular regulation
and several diseases. While it is thought that Rheb GTPase regulates mTOR, acting immediately upstream, while
raptor is immediately downstream of mTOR, direct interactions have yet to be verified in living cells, furthermore
the localisation of Rheb has been reported to have only a cytoplasmic cellular localization.
Results: In this study a cytoplasmic as well as a significant sub-cellular nuclear mTOR localization was shown ,
utilizing green and red fluorescent protein (GFP and DsRed) fusion and highly sensitive single photon counting
fluorescence lifetime imaging microscopy (FLIM) of live cells. The interaction of the mTORC1 components Rheb,
mTOR and raptor, tagged with EGFP/DsRed was determined using fluorescence energy transfer-FLIM. The
excited-state lifetime of EGFP-mTOR of ~2400 ps was reduced by energy transfer to ~2200 ps in the cytoplasm and
to 2000 ps in the nucleus when co-expressed with DsRed-Rheb, similar results being obtained for co-expressed
EGFP-mTOR and DsRed-raptor. The localization and distribution of mTOR was modified by amino acid withdrawal
and re-addition but not by rapamycin.
Conclusions: The results illustrate the power of GFP-technology combined with FRET-FLIM imaging in the study of
the interaction of signalling components in living cells, here providing evidence for a direct physical interaction
between mTOR and Rheb and between mTOR and raptor in living cells for the first time.
Keywords: FLIM, FRET, mTOR, GFP, Raptor, RhebBackground
The mammalian target of rapamycin (mTOR) signalling
pathway has a key role in cellular regulation and is in-
volved in multiple diseases. mTOR is a central regulator
of cell growth, aging, ribosome biogenesis, protein synthe-
sis, actin-cytoskeletal organization, autophagy and meta-
bolism. It also plays a vital role in coupling cell growth via
signalling pathways, according to the availability of nu-
trients and cellular energy supplies and oxygen [1]. mTOR
forms two distinct heteromeric complexes, mTORC1 and
mTORC2. mTORC1 contains mTOR, raptor (regulatory
associated protein of mTOR), mLST8 and PRAS40 [2-5],* Correspondence: chris.stubbs@stfc.ac.uk; stan.botchway@stfc.ac.uk
1Central Laser Facility, STFC, Rutherford Appleton Laboratory, Research
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reproduction in any medium, provided the orwhilst mTORC2 contains mTOR, rictor (rapamycin-
insensitive companion of mTOR), mLST8, mSin1 and
protor [6-9], raptor and rictor being specific components
of mTORC1 and mTORC2 respectively.
Rheb (Ras homologue enriched in brain) is a small
GTP-binding protein that has been shown to promote cell
growth and control cell size in mammalian cells and also
in Drosophila melangaster [10], is a key protein that relays
upstream signals to regulate mTORC1. The involvement
of Rheb in these important complexes is still unclear.
However, Rheb is reported to bind directly to the amino
terminal lobe of the mTOR catalytic domain and to acti-
vate mTOR kinase in a GTP/GDP-dependent manner
[11] in cell lysate studies, although a direct interaction is
difficult to prove using this approach. Furthermore, evi-
dence using the pull-down assay approach suggests Rhebtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mTORC1 and mTORC2 complexes play key roles in sev-
eral pathways that are involved in human cancers and in
other important diseases, making the development of inhi-
bitors of these pathways a high priority for the pharma-
ceutical/ biotechnology industries.
It has been reported that Rheb–TSC2 GAP activity may
stimulate mTOR phosphorylation and while Rheb is con-
sidered a “component” of the mTOR signalling complex, as
yet there is no convincing evidence of a direct interaction
reported between Rheb and mTOR. It is also possible that
Rheb may bind to and activate mTOR-interacting proteins
such as rictor, raptor or mLST8 rather than interacting
with and activating mTOR directly [1].
Raptor interacts with mTOR to form a nutrient-
sensitive complex that signals to the cell growth machinery
[2,3]. It has also been reported that the stability of the
mTOR-raptor complex increased when cells were starved
of amino acids or energy generating materials [3]. How-
ever, other studies [2] obtained no evidence for changes in
mTOR-raptor complex stability when cells were treated
with nutrient-rich and nutrient-poor conditions. The rea-
son for the discrepancy in the observations between these
two studies [2,3] is unclear since the former report [2]
failed to demonstrate an impact of the nutrient status on
the stability of the mTOR–raptor complex in mammalian
cells using similar experimental conditions [3,13]. Further-
more there is some evidence that raptor functions as a
mTOR scaffolding protein, the binding to the TOR signal-
ling (TOS) motif of mTOR substrates being thought to be
necessary for their effective mTOR-catalyzed phosphoryl-
ation in vivo [14]. Hence the dynamic aspects of the inter-
action between mTOR, Rheb and raptor in living cells
requires new approaches for the detection of interaction,
such as provided by the fluorescence resonance energy
transfer – fluorescence lifetime imaging (FRET-FLIM)
technique for observation of appropriately labelled materi-
als in an active environment [15-18].
Several proteins involved in the mTOR signalling path-
way, including phosphoinositide 3-kinase (PI3K) [19],
PDK1 [20], Akt [21], phosphatase and tensin homolog
(PTEN) [22], tuberin [23], and p70S6K and its substrate S6
[24] have been found to localize in both the cytoplasm and
the nucleus. In addition, mTOR, but not raptor, has been
reported to shuttle between the cytoplasm and nucleus
[25-27]. By contrast, a nuclear localization of Rheb has not
been reported.
Fluorescence lifetime imaging utilizing confocal single
and multiphoton excited state emission microscopy
together with time-correlated single photon counting
(TCSPC) provides an unambiguous determination of the
location of fluorophores. With the discovery of green
fluorescent protein (GFP) technology, significant new in-
formation on the inner workings of the living cell hasbeen made possible through imaging approaches. The
interaction of proteins in cells can be followed by utilizing
steady state FRET between protein pairs tagged with
appropriate GFP-fluorophores, such as enhanced GFP
(EGFP, enhanced green fluorescent protein) and mono-
meric red fluorescent protein (DsRed). With steady state
FRET the donor fluorophore, in this case GFP, is excited
and would fluoresce but instead the excited state energy is
re-absorbed by an acceptor fluorophore, in this case
DsRed, which itself then fluoresces at a longer wavelength,
provided the two fluorophores, and by inference the pro-
teins to which they are attached, are close (within ~7 nm).
Monitoring steady state FRET intensities is notoriously
difficult and requires difficult corrections etc. A better
method is to monitor the decreased donor lifetime which
is independent of the problems associated with steady
state intensity measurements and is evidence for a direct
physical interaction. We have previously shown that a re-
duction of as little as ~200 ps in the excited state lifetime
of the GFP labelled protein represents quenching through
a protein-protein interaction [15-17]. In addition two-
photon-excitation fluorescence lifetime imaging micros-
copy (2P-FRET-FLIM) analysis as used here [15-17], pro-
vides several advantages over the standard single photon
method, including reduced cellular cytotoxicity of the exci-
tation light and reduced photobleaching of the fluoro-
phore. Greater sensitivity of the set-up is achieved through
reduced sensitivity of the excitation light (>900nm) by the
photomultiplier tube as a detector. Using the sensitive
advanced imaging technique of time-correlated single pho-
ton counting coupled with fluorescence lifetime imaging
and molecular GFP fusion technology, it was possible for
the first time to probe directly the nature of the inter-
action between Rheb, mTOR and raptor as well as raptor
and mTOR whilst providing new insights into their sub-
cellular localization.
While the GFP-expression approach is excellent for
providing evidence of potential interaction of proteins in
living cells, since it is an over-expression, one cannot ex-
clude the possibility that the labelled proteins may not
interact at their lower natural endogenous levels. Thus
there will always be some uncertainty in the approach.
However, alternative methods for assessing interactions
are more limiting as they all involve pull-down assays
after solubilisation of the whole cell or cell fractionation
which destroys localization information and itself intro-
duces interaction artefacts as it mixes organelle contents.
For these reasons the GFP approach is widely used and
is the best method available for assessing potential inter-
actions of cell components as long as one is aware of its
limitations.
In this study, we report on the significant nuclear
localization of Rheb together with high levels of a constant
pool of mTOR (but not raptor) in HEK293, CHO and
Figure 2 EGFP-Rheb and DsRed-Rheb expression in mammalian
cells. A) HEK293 cells and B) HeLa cells were transiently transfected
with EGFP-Rheb (left panel) and DsRed-Rheb vector (right panel).
24h following transfection, and the live cells analyzed under a Nikon
TE2000 U confocal microscope. Bar 8 μm.
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ingly, raptor was absent from the cell nucleus under all
conditions investigated. A constant and direct interaction
was observed between Rheb-mTOR and raptor-mTOR,
but not between Rheb and raptor in the cell cytoplasm.
Results
Rheb localizes to both cytoplasmic and nuclear regions in
mammalian cells
The functionality of EGFP-Rheb was first examined by
Western blots using an antibody to the phosphorylated
form of S6-K1 as induced by mTORC1 signalling (see
Figure 1). S6-K1-phosphorylation (Row D, lane 2) was
increased due to EGFP-Rheb expression, which was
therefore functional. The data indicate that it is Rheb
that largely controls the level of S6-K phosphorylation. If
either of the mTOR or raptor had been non-functional
they would have reduced the level of S6-K phosphoryl-
ation, in fact it was increased by a small but significant
amount by EGFP-mTOR and DsRed-raptor expression.
Therefore EGFP-mTOR and DsRed-raptor were likely
also functional.
EGFP and DsRed tagged proteins were observed to be
efficiently expressed in several mammalian cell lines under
investigation. Figure 2 shows confocal images of the tran-
siently expressed fluorescent proteins fused with Rheb
protein in HEK293 and HeLa cells. The transfection ex-
pression levels for the cell lines used in this study differed
somewhat, in that HEK293 cells showed more than 80%
transfection efficiency, compared to CHO and HeLa cells
at ~60% (CHO image data not shown), likely due to differ-
ences in the optimal conditions for transfection for theFigure 1 Functionality of EGFP-Rheb, EGFP-mTOR and DsRed-
raptor determined by S6-kinase activity. EGFP-Rheb, EGFP-mTOR
and DsRed-raptor were expressed in HEK cells and gels were run and
blotted with the respective antibodies to Rheb, mTOR, raptor and S6-
kinase (thr389). The expressed level of EGFP-Rheb is shown in Row A,
lanes 2, 5 and 7 but the antibody was unable to pick up endogenous
levels. The endogenous levels of mTOR can be seen in Row B, lanes 1,
2, 4 and 7 (with increased density when EGFP-mTOR is expressed
(lanes 3, 5 and 6, high MW too close for large migration difference).
The endogenous levels of raptor can be seen in Row C, lanes 1, 2, 3,
and 5, with lanes 4, 6 and 7 showing DsRed-raptor expression.three cell lines. Fluorescently tagged Rheb, raptor and
mTOR were confirmed by SDS-PAGE and gel electro-
phoresis in that the correct fluorescent protein was tagged
to mTOR, Rheb and raptor and that they were con-
structed and expressed correctly (data not shown). The
main localization of Rheb and mTOR appeared to be the
perinuclear regions in the Golgi and ER.
To determine if EGFP-Rheb was present within the
cell nucleus, we obtained a 3D-multiphoton TCSPC
image Z-stack of HEK293 cells expressing the fluores-
cent protein (Figure 3A-K). Using this technique, it was
possible to observe the presence of EGFP-Rheb protein
throughout the cell with significant expression levels
within both cytoplasmic and nuclear regions. Taking into
account the average fluorescence intensity of EGFP-
Rheb within the cytoplasmic/Golgi regions (52000 pho-
ton counts per second, Figure 3F red box), compared to
that within the nuclear region (26000 photon counts per
second, Figure 3F yellow box), we can estimate Rheb ex-
pression levels of ~40% within the cell nucleus and
~60% within the cytoplasm, the Golgi apparatus and ER
together. In HEK293 cells expressing EGFP-Rheb a cyto-
plasmic and nuclear localization was found (Figure 4). In
addition we performed immunohistofluorescent staining
using an anti-Rheb antibody (Figure 4), although, as is
well known, Rheb antibodies are of somewhat low
quality, perinuclear and nuclear staining is apparent.
Co-localization studies using a Golgi fluorescent
probe (BODIPY Texas Red ceramide, Invitrogen) and a
probe for the endoplasmic reticulum (ER-Tracker Red;
Figure 3 3D Stack images of multiphoton-induced fluorescence of HEK293 expressing EGFP-Rheb. Fluorescence from TCSPC images of
live HEK293 cells was acquired using multiphoton excitation (920 nm laser excitation, 520 nm emission) following 24h transfection. Raw data
presented without further image processing. Images show clear Rheb nuclear localization. Yellow and red boxes (F) refer to nuclear and ER/Golgi
regions taken for comparative photon count. Image size 120x100 μm.
Figure 4 Immunohistochemical staining of Rheb. HEK293 cells
expressing EGFP-Rheb (LEFT PANEL) or cells fixed in 4%
formaldehyde and treated with anti-Rheb antibody in conjugation
with Texas red-labelled secondary antibody (RIGHT PANEL) were
imaged with confocal microscopy. Bar 10 μm.
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EGFP-Rheb localized to Golgi and ER (see Figures 5, 6).
mTOR shows some nuclear but mainly ER and Golgi
localization in mammalian cells
The localization of mTOR in HEK293, HeLa and CHO
cells was studied by transient transfection with EGFP-
tagged at either end of mTOR. Cells were examined for
expression following 24h and 48h of transfection. HEK293
and HeLa cells showed mTOR expression mainly in the
cytoplasm with some detectable but weak presence within
the cell nucleus as shown in Figure 7.
Using the TCSPC technique, we observed the average
percentage count in three independent experiments to be
~20% EGFP-mTOR in the nucleus and ~80% within cyto-
plasmic regions of HEK293 cells (error of ± 6%, SD in
both regions) (data not shown) (note that this quantifica-
tion information is lost within standard confocal laser
Figure 5 Sub-cellular localization of Rheb on ER. A) HEK293 cells; B) HeLa cells were transiently transfected with EGFP-Rheb. Twenty-four
hours following transfection cells were stained with 1 μM ER Tracker red and live cells analyzed by confocal microscopy. The images reveal that
Rheb localizes to the ER Bar 8 μm.
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pression of EGFP-mTOR observed in populations of HeLa
cell was ~32% (± 8%) while in CHO cells the number was
~26% (± 6% in both regions) (data not shown).Raptor expression is observed only in the cytoplasm
The localization of raptor was studied by transiently
transfecting HEK293, HeLa and CHO cells with a vector
for DsRed-raptor. Figures 8A, B show that in HEK293
cells DsRed-raptor was predominantly within the cyto-
plasm, at 24h and 48h after transfection in punctate
structures. Transient transfection of DsRed-raptor inFigure 6 Sub-cellular localization of Rheb on Golgi. A) HEK293 cells; B)
hours after transfection cells were stained with 5 μM BODIPY TR C5 cerami
that Rheb localizes to the Golgi. Bar 8 μm.HeLa (Figure 8C) and CHO cells (Figure 8D) showed a
similar pattern of expression.
EGFP-mTOR shows a direct interaction with DsRed-Rheb
that is unaffected by rapamycin
To investigate mTOR binding-partner interactions, transi-
ently expressing EGFP-mTOR in HEK293 and HeLa cells
were first obtained and analyzed using FLIM, to obtain
the control excited state lifetime (donor chromophore)
48h after transfection (Figure 9). A lifetime image of
HEK293 cells transfected with EGFP-mTOR for 48h is
shown in Figure 9, with the corresponding FLIM image.
In three independent experiments the lifetime of EGFP-HeLa cells were transiently transfected with EGFP-Rheb. Twenty-four
de and live cells analyzed by confocal microscopy. The images reveal
Figure 7 EGFP-mTOR expresses predominantly in the
cytoplasm of mammalian cells. EGFP tagged mTOR expression
was studied in HEK293, HeLa and CHO cells. The cells were
transiently transfected with EGFP tagged mTOR and expression was
analyzed in live cells following 48h of transfection using a Nikon
TE2000 U inverted microscope and EC1 confocal system. (EGFP-
mTOR; EGFP tagged at the N-terminal of mTOR and mTOR-EGFP;
EGFP tagged at the C-terminal of mTOR). Bar 8 μm.
Figure 8 Sub-cellular localization of transiently transfected
DsRed-raptor in different mammalian cell types. DsRed tagged
raptor was expressed in HEK293 cells for A) 24h and B) 48h, HeLa
cells for 48h, C) and CHO cells for 48h, D). Live cells were analyzed
for various times following transfection using a Nikon TE2000 U
confocal microscope. Bar 8 μm.
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± 100 ps. EGFP-mTOR located within the nucleus showed
a similar lifetime to that in the cytoplasm.
HEK293 cells co-expressing EGFP-mTOR with DsRed-
Rheb over a 48h of transfection is shown in Figure 10A.
The average excited state lifetime of the EGFP-mTOR in
the presence of DsRed-Rheb was determined to be 2200 ±
50 ps in three independent experiments, the reduced level
due to a direct interaction between Rheb and mTOR, due
to energy transfer from EGFP to DsRed. In HeLa cells, a
similar quenching in the lifetime of EGFP-mTOR (2100 ±
100 ps) was observed in co-transfected cells again showing
a direct interaction and evidence for a direct mTOR/Rheb
interaction in HEK293 cells was observable whether the
EGFP was at the N- or C- termini of mTOR (data not
shown).
Analysis of the average lifetime of the EGFP-mTOR
from the nuclear regions in HEK293 cells was determined
to be ~2000 ± 100 ps in three independent experiments.
HeLa cells showed similar expression in the nuclear
regions of EGFP-mTOR and DsRed-Rheb co-transfected
cells (data not shown). Quenching in the lifetime of the
donor (EGFP-mTOR) from 2400 ± 100 ps to 2000 ± 100
ps in the nuclear regions indicates that EGFP-mTOR and
DsRed-Rheb interact (due to excited state energy transfer)
differently (i.e. they are closer) in the cell nucleus than in
the cytoplasm, likely brought about by a different con-
formation of the mTOR/Rheb complex. Importantly, in
this study EGFP-mTOR and DsRed-Rheb were consist-
ently observed to be expressed at similar levels in HEK293
cells (~40%), whilst these levels were different when
expressed alone (~30% for mTOR alone but ~40% for
cells also expressing Rheb).
The effect of rapamycin on the direct interaction of
EGFP-mTOR and DsRed-Rheb expressed in HEK293 cells
was determined by a 24 h treatment (100 nM). The EGFP
lifetime (2200 ± 100 ps, data of three independent experi-
ments) was unaffected by the treatment showing rapamy-
cin had no impact on the interaction (see Figure 10B).
Although the interaction of Rheb with mTOR has been
widely inferred by indirect approaches this is the first live
cell imaging work showing the interaction occurs and
does so in specific regions of the cell. Although it suffers
from the disadvantage that we are looking at over-
expression it enables us to examine the mechanisms and
consequences of the interaction in a living cell.
Raptor interacts directly with mTOR but not with Rheb
and the mTOR-raptor interaction is unaffected by
rapamycin
EGFP was tagged to either end of mTOR and DsRed was
tagged to the N-terminal of raptor and lifetimes measure-
ments of GFP observed. The excited state lifetime of the
donor EGFP-mTOR was determined in HEK293 cells co-
Figure 9 Fluorescence lifetime imaging of EGFP-mTOR expressed in HEK293 cells. A) Confocal image of EGFP-mTOR expressed in HEK293
cells following 48 h of transfection; B) Lifetime image of the same cells (colour coding for the lifetimes is shown in (C)), image size 120 x 110 μm;
C) Lifetime distribution taken for the entire area (white border) shown in (B). The data collection time for lifetime images were optimally 3
accumulations of 30 sec. with an image dimension of 128×128 pixels (the blue cross lines are for single pixel lifetime values which were not
used). A fluorescence lifetime value was determined from the distribution centre in (C), representing a value for the entire area shown in (B) and
was ~2450 ± 100 ps, taken from three independent experiments.
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whole area of the image was 2300 ± 100 ps (Figure 11A).
The corresponding confocal images of the co-expressed
cells excited separately at 488 nm for EGFP-mTOR and
543 nm for DsRed-raptor, respectively, as shown in
Figure 11A, shows high expression levels (>70% of cells)
of both proteins. The quenched lifetime of the donor
fluorophore in co-transfected cells suggests that theFigure 10 DsRed-Rheb direct interaction with EGFP-mTOR in HEK293
488 nm excitation images of EGFP-mTOR (co-expressed with DsRed-Rheb,
Rheb, without (A) and with (B) rapamycin (100 nM) treatment for 24 h. (A,
coding for the lifetimes is shown in the RIGHT PANELS). (A, B) RIGHT PANE
shown in the MIDDLE PANELS. The lifetime value from the data in (A) RIGH
quenching by DsRed (attached to Rheb) from ~2450 ± 100 ps for EGFP alo
interaction. The data in (B) RIGHT PANEL for the lifetime of the EGFP (attac
the quenching indicating it does not impact on the direct interaction. The
of 30 sec. with an image dimension of 128×128 pixels, bar 8 μm.EGFP-mTOR and DsRed-raptor directly interact under
normal growth conditions within the perinuclear regions,
as indicated by Golgi and ER confocal co-localization data.
Similar results were also observed in HeLa and CHO cells
(data not shown). Analysis of cells co-expressing EGFP-
Rheb (donor) and DsRed-Raptor (acceptor) in HEK293
and HeLa cells gave an unquenched excited state average
lifetime of the donor of 2400 ± 100 ps indicating a lack ofcells and lack of effect of rapamycin. (A, B) LEFT PANELS: Confocal
after 48 h of transfection) and 543 nm excitation images of DsRed-
B) MIDDLE PANELS: Lifetime images of the co-transfected cells (colour
LS The lifetime distributions taken for the entire area (white border) as
T PANEL for the EGFP (attached to mTOR) is reduced due by
ne (see Figure 9) to 2200 ± 100 ps (n=3) here, thus showing a direct
hed to mTOR), after treatment with rapamycin there was no relief of
data collection time for lifetime images was optimally 3 accumulations
Figure 11 EGFP-mTOR direct interaction with DsRed-raptor in HEK293 cells and lack of effect of rapamycin. (A, B) LEFT PANELS: Confocal
488 nm excitation images of EGFP-mTOR (co-expressed with DsRed-raptor, after 48 h of transfection) and 543 nm excitation images of DsRed-
raptor, without (A) and with (B) rapamycin (100 nM) treatment for 24 h. (A, B) MIDDLE PANELS: Lifetime images of the co-transfected cells
(colour coding for the lifetimes is shown in the RIGHT PANELS). (A, B) RIGHT PANELS The lifetime distributions taken for the the region taken
here is within the area of the thin red line (not the entire area as previous Figures) as shown in the MIDDLE PANELS. The lifetime value from the
data in (A) RIGHT PANEL for the EGFP (attached to mTOR) is reduced due to quenching by DsRed (attached to raptor) from ~2450 ± 100 ps for
EGFP alone (see Figure 9) to 2300 ± 100 ps (n=3) here, thus showing a direct interaction. The data in (B) RIGHT PANEL for the lifetime of the
EGFP (attached to mTOR) for the cell demarked by the thin red line (the cell below being omitted as it is not expressing DsRed-raptor, see LEFT
PANEL), after treatment with rapamycin there was no effect on the lifetime centre (2300 ps ± 100 ps). The data collection time for lifetime images
was optimally 3 accumulations of 30 sec. with an image dimension of 128×128 pixels, bar 8 μm.
Figure 12 Amino acid starvation and re-stimulation does not affect the direct interaction between EGFP-mTOR and DsRed-Rheb in
perinuclear regions. (A-C) LEFT PANELS: Confocal 488 nm excitation images of EGFP-mTOR (co-expressed with DsRed-Rheb, after 48 h of
transfection) and 543 nm excitation images of DsRed-Rheb, for HEK293 cells serum-starved overnight and then amino acid starved in D-PBS for 1
h (A) following which the amino acids were added back (B, C). Punctate structures appear after amino acid removal and disappear after adding
back the amino acid and appear not to contain Rheb. A-C) MIDDLE PANELS, Lifetime images of the co-transfected cells (colour coding for the
lifetimes is shown in the RIGHT PANELS). (A-C) RIGHT PANELS The lifetime distributions taken for the cell area (within red line) as shown in the
MIDDLE PANELS. A, revealing both quenched and unquenched EGFP reflecting the mixture of perinuclear mTOR/Rheb and punctate mTOR), as
reflected in the lifetime image; B) the same cells after 10 min of amino acid re-stimulation; C) after 60 minutes of amino acid re-stimulation when
the punctate structures had disappeared. At all time-points the area marked by the white circle, mainly ER/Golgi, shows a quenched lifetime i.e.
Rheb interacting with mTOR. Bar 8 μm.
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shown).
HEK293 cells were co-transfected with EGFP-mTOR
and DsRed-raptor, and 24h later were treated with rapa-
mycin at 2h or 24h. There was no effect on the EGFP-
mTOR (quenched) excited state lifetime (~2300 ± 100 ps)
indicating that the interaction was not affected by rapamy-
cin treatment (Figure 11B). Although there may be mar-
ginal unquenched EGFP (shoulder at 2400–2500 ps,
Figure 11B RIGHT PANEL), however, because the
mTOR-raptor interaction is not as close as Rheb-mTOR
(quenched EGFP lifetime 2300 ps vs 2200 ps, respectively)
it is difficult to be certain if this indicates marginal effects
of Rapamycin.
Amino acid starvation modifies the localization and the
nature of the direct interaction of mTOR with Rheb
Under conditions of amino acid starvation, punctate
structures or granules were observed for EGFP-mTOR
(Figure 12A). When amino acids were added back the
punctuate structures gradually diminished and had dis-
appeared by ~60 mins (see Figure 12C), or much moreFigure 13 Amino acid starvation and re-stimulation effect on the dire
PANELS: Confocal 488 nm excitation images of EGFP-mTOR (co-expressed
images of DsRed-raptor, for HEK293 cells serum-starved overnight and then
acids were added back (B, C). Punctate structures appear after amino acid
MIDDLE PANELS, Lifetime images of the co-transfected cells. The colour co
distribution of the area of EGFP-mTOR and DsRed-raptor co-expressing cell
The lifetime distributions taken for the cell area (within red line) as shown
interaction of mTOR/raptor both in the punctate structures and other regio
2350 ps, possibly indicating that in the punctate structures there may still b
starvation conditions (compare Figure 11). (A cells with only EGFP-mTOR e
stimulation (B, C) the punctate structures disappear and the quenched lifetrapidly after addition of serum (FCS) alone (data not
shown). Also amino acid starvation and re-stimulation in
HEK293 cells led to a distinct region of interaction, indi-
cated by different levels of EGFP-lifetime quenching, to
~2100 ps in the perinuclear region and to ~2400 ps in the
punctuate structures. Again the results indicate that Rheb
and mTOR may interact differently in the two regions. It is
important to note that the EGFP-Rheb subcellular
localization and distribution is unaffected by this treatmentAmino acid starvation does not affect the localization or
the direct interaction of mTOR with raptor
The mTOR-raptor interaction was also observed in
small punctate-like structures in the cytoplasm as for
Rheb in the perinuclear region, under amino acid starva-
tion conditions (Figure 13). Under conditions of amino
acid starvation and subsequent re-addition showed no
significant change in the EGFP-mTOR lifetime (2200 ±
100 ps) (Figure 13) and therefore we conclude the inter-
action between EGFP-mTOR and DsRed-raptor remains
unchanged. Also the localization and distribution ofct interaction between EGFP-mTOR and DsRed-raptor. (A-C) LEFT
with DsRed-raptor, after 48 h of transfection) and 543 nm excitation
amino acid starved in D-PBS for 1 h (A) following which the amino
removal and disappear after adding back the amino acid. (A-C)
ding for the lifetime is shown in the right panel which is a lifetime
s (area marked by red line in the middle panel) (A-C) RIGHT PANELS
in the MIDDLE PANELS. A, revealing quenched EGFP reflecting a direct
ns. Note that the lifetime of EGFP mTOR is slightly reduced, to about
e some mTOR-raptor interaction but 'looser' under amino acid
xpression is shown for comparison, white circle). After amino acid re-
ime for the EGFP returns to <2300 PS.
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treatment.Discussion
This study is the first to show a direct interaction between
Rheb and mTOR in specific regions of living cells. Al-
though previous studies have suggested an interaction
using pull-down approaches [11], the ability to be able to
study localization and interaction on a (live) cell-by-cell
basis is important when studying a signalling complex
which may play differing roles simultaneously in different
parts of the cell, as appears to be the case with the
mTORC1 complex. The FRET-FLIM approach offered
two other advantages. It was able to show a direct inter-
action of both Rheb and raptor with mTOR, also different
conformations of the interacting components could be
distinguished by this technique, such information being
unavailable using a pull-down assay approach.
Both EGFP- and DsRed-tagged Rheb appeared to locate
in perinuclear regions in the Golgi and ER, with no differ-
ence in the expression levels in transfected cells. Previous
studies of GFP-tagged Rheb have also shown such peri-
nuclear accumulation [28-30]. The insensitive nature of
confocal image acquisition (i.e., because of analogue signal
thresholding) can make it difficult to set the threshold of
standard confocal photomultiplier tubes without losing
weaker signals. Consequently, gain and background levels
can lead to either signal loss or oversampling. The use of
highly sensitive time-correlated single photon counting,
such as TCSPC, allows fluorescence photons to be
detected above any background level as well as the ability
to quantify the number of photons detected. Thus, in this
current study using TCSPC, we report persistent and ob-
servable EGFP-Rheb presence within both cytoplasmic
and also the sub-cellular nuclear regions, although the sig-
nal from the nucleus is somewhat weak and it may pos-
sibly be due to the fact that it is over-expressed. However,
regarding a nuclear Rheb presence it is important to note
(i) it has been suggested that mTOR shuttles between the
nuclear region and cytoplasm [25-27], and (ii) that
mTORC1 plays a key role in ribosome biogenesis, a
process which occurs in the nucleolus [1]. The presence
of Rheb within the cellular nucleus suggests it might inter-
act with mTOR in that compartment. Although the role
for Rheb within the cell nucleus is unclear and whether it
simply resides there or can indeed shuttle in and out is
not known, however, it is likely to have a role in directing
mTOR localization and therefore downstream signalling
within the nucleus. The interaction between Rheb and
mTOR observed is unlikely to be due to mis-localization
since randomly distributed protein molecules will be suffi-
ciently far apart (>>10 nm) to limit direct stable
interaction.It has also been reported by using timed imaging of live
cells that, following brief association with ER, EGFP-Rheb
localizes to highly-ordered distinct structures within the
cytoplasm that display the characteristics of Golgi mem-
branes [28]. Rheb was also reported to be localized with
mitochondria [31], along with FKBP38 and mTOR [32]. It
has also been shown that GFP-tagged Rheb co-localizes
with Rab7, a marker for endosomal and lysosomal struc-
tures [33]. Our studies did not reveal a co-localization of
EGFP-Rheb with Mitotracker (data not shown) in keeping
with observations that ectopically expressed Rheb does
not localize to mitochondria [30]. Previously it has been
reported that EGFP-tagged Rheb showed a granule-like
fluorescence pattern in the cytoplasm, while not being
found at the plasma membrane or in the nucleus, and that
it has mainly an endomembrane localization [34]. How-
ever, several upstream regulators of mTOR have been
reported to be expressed in the nucleus as well as in the
cytoplasm and mTOR plays an important role in the regu-
lation of translation. Evidence for a nuclear localization of
mTOR has also been provided previously based on data
from immunofluorescence in conjunction with cell frac-
tionation and Western blot analysis [25-27].
Other components of the pathway such as tuberin,
Rheb and p70S6K also localize to the cytoplasm (see
Introduction). Indeed, tuberin, an upstream regulator of
Rheb has been reported to localize in the cytoplasm and
nucleus [23], similar to p70S6K, one of the major sub-
strates of mTORC1 [24]. In addition, mTOR was also
found to shuttle between the cytoplasm and the nucleus,
this being required to regulate the mitogenic stimulation
of p70S6K activation and 4E-BP1 phosphorylation [25].
This study provides supporting evidence for the nuclear
localization of Rheb for the first time as well as mTOR
in live cells. The nuclear localization of mTOR is likely
an evolutionarily conserved phenomenon and may play
an essential role in mTOR signalling and functioning as
previously suggested [35]. With regard to raptor, previ-
ous studies using immunofluorescence have shown that
raptor is localized within cytoplasm [33]. The live cell
confocal imaging here also showed a cytoplasmic
localization and absence from the nucleus. Furthermore
lifetime data revealed that raptor interacts with mTOR
both in the cytoplasm and also within the amino-acid
starvation-induced punctate structures within the cyto-
plasm (see below).
The involvement of Rheb in the mTORC1 complex
has remained an important point of interest since it was
shown to interact with mTOR due to the potential of its
ability to control activity of the complex through its
GDP/GTP bound state [11,12,36]. Rheb is reported to
bind directly to the amino terminal lobe of the mTOR
catalytic domain and to activate mTOR kinase in a
GTP/GDP-dependent manner in cell lysate studies.
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shown to associate with mLST8 and with raptor [11,12].
One of the key goals of this study was to investigate
whether Rheb and mTOR directly interact in living cells
and whether this interaction is affected by conditions
where mTORC1 signalling is impaired (implemented via
nutrient starvation or rapamycin treatment). The immu-
noprecipitation/cell lysate methods previously used are
susceptible to artifacts due to the lysis conditions used
and do not distinguish between direct and indirect inter-
actions. Here, we were able to demonstrate a direct inter-
action of DsRed-Rheb with EGFP-mTOR (irrespective of
whether the DsRed was bound to the C- or N- termini of
Rheb. A direct DsRed-raptor interaction with EGFP-
mTOR was also shown. By contrast, the lifetime of EGFP
of EGFP-Rheb was not reduced when co-expressed with
DsRed-raptor (results not shown), consistent with them
not interacting directly, however, considering the large size
of mTOR (280 kDa) compared to those of Rheb (21 kDa)
and raptor (150 kDa), it is possible that their positions on
the mTOR are further apart than the distance for efficient
FRET (~7 nm). Therefore the results are consistent with a
model where the signal must pass from Rheb via mTOR
to raptor and on to downstream kinases. From the recent
cryo-electron microscopy structure the N-terminus of
mTOR would appear to interact with the flat face of a sin-
gle raptor molecule forming one interface [37], while C-
terminal of mTOR interacts with the side of a second rap-
tor molecule forming a second interface. The interaction
data from the present live cell study are consistent with
the proposed model of this structural study where there
may be more than one raptor molecule binding to mTOR.Figure 14 Rheb expression and translocation into the nucleus. Rheb a
interact with mTOR. Rheb possibly binds to mTOR to shuttle between nucl
yet unknown function (scheme modified from [42].There was evidence from different levels of EGFP-
mTOR lifetime quenching in the cytoplasm and the nu-
cleus by DsRed-Rheb that the nature of the direct inter-
action in these two regions may differ, furthermore, the
finding of significant Rheb in the nucleus is a new finding
and suggests an increased levels of mTOR also within the
cell nucleus. The mechanism for the increased nuclear
concentration and details of the nature of the interaction
remain to be investigated. From these studies, a revised
Rheb binding to mTOR is proposed to include Rheb
nuclear localization (Figure 14). It is clear the Rheb
localization in the nucleus has important implications for
mTOR signalling.
There is ongoing interest in the mechanism of action of
the antagonistic action of rapamycin on mTOR signalling,
not least due to its anti-cell growth/cancer drug potential.
Using the GFP/FRET-FLIM approach the addition of
rapamycin was not seen to affect the localization of either
mTOR, Rheb or raptor, nor their interaction. Also, in
agreement with other studies [38], neither amino acid
starvation nor rapamycin treatment had an influence on
mTOR-Rheb interactions. Regarding the effect of rapamy-
cin on mTOR-raptor interactions, Oshiro and co-workers
[39] reported that rapamycin dissociates the interaction
while others [2] did not observe dissociation after rapamy-
cin treatment in agreement with a bead-pull-down assay
[7] and our results. Importantly, our data from living cells
imply that rapamycin works by a mechanism other than
by a complete dissociation of the mTOR-raptor interac-
tions. Rapamycin may act by other mechanisms, as has
been suggested [14], or by directly acting on the catalytic
activity of mTORC1 [40]. Our observation is also inctivation by diverse extracellular signal enables Rheb to directly
eus and cytoplasm or it may translocate alone to the nucleus for as
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of rapamycin-FKBP12 to the FRB domain of mTOR
induces an allosteric conformational change that reduces
the intrinsic catalytic activity of mTORC1. Additional
work is still required to understand how rapamycin inhi-
bits some of the functions of mTORC1.
The punctate localization of mTOR is brought about
by amino acid withdrawal, after re-addition of amino
acids the punctate structures dissipate (at least as visua-
lized by EGFP-mTOR). While Rheb did not associate
with these structures, there was heterogeneity in the
raptor distribution as it seemed to co-associate with
mTOR in some but not all cases within a single cell.
This being an over-expression and the lifetime analysis
being averaged over an entire cell makes interpretation
difficult in terms of what would be occurring in the
endogenous situation. However, it does seem that under
conditions of amino acid withdrawal, the mTOR-raptor
association is looser (inactive?). This is seen as a
quenching (revealed as reduced mTOR lifetime) of the
EGFP (attached to mTOR) by the DsRed (attached to
raptor) under amino acid withdrawal conditions being
less than in the amino acid presence. mTOR activity is
regulated by amino acid availability via a “ragulator”
complex (includes RAG GTP'ases) directly associating
with mTOR, as recently described [41], where punctate
structures were also observed. However, in that study it
was shown that in the absence of amino acids, mTOR is
found in punctate structures in cells, but then concen-
trates in larger structures (lysosomes) after amino acid
addition, whereas we are showing mTOR in the punc-
tate structures as a result of amino acid starvation. It is
possible that over-expression caused our result or it
could be some other difference.
Conclusions
In summary, Rheb, mTOR and raptor mainly reside on
Golgi/ER like structures, where mTOR directly interacts
with both Rheb and raptor, shown here for the first time
in living cells using FRET-FLIM methodology. A clear
localization of Rheb within the mammalian nucleus was
also shown (scheme 1). Rapamycin did not affect the ele-
vated levels of mTOR-Rheb or mTOR-raptor interactions,
implying that rapamycin does not inhibit mTORC1 signal-
ling by disrupting this complex. Amino acid starvation
resulted in formation of complexes (containing EGFP-
mTOR) that appear as punctuate structures which dissi-
pate after re-addition of amino acids or serum. The inter-
action of raptor-mTOR was not affected by the lack of
amino acids whilst the Rheb-mTOR association was 'loo-
sened' within the granules but not in the perinuclear
regions. Although GFP-technology is very widely used,
one needs to be aware of the disadvantage in that the
method uses over-expression of the tagged protein whichmay impact on the interactions and downstream target ac-
tivities. For this reason caution is required in interpreta-
tions and minimally effects on these downstream activities
needs to be checked to confirm functionality, as we have
done here using S6-kinase activities. Overall we demon-
strate that the advanced time-resolved FRET-FLIM
technology provides a powerful protocol to investigate sig-
nalling pathways and it highlights the physical capabilities
of the technique to provide much needed information for
developing and testing drugs designed to target specific
pathways in real-time in living cells.
Methods
Materials and Cell culture
The cDNA for Rheb was from Gene Service, raptor from
Addgene and mTOR from Origene. Cellular markers for
Golgi, ER and mitochondria were obtained from Molecular
Probes, Invitrogen. Rapamycin was purchased from Sigma.
HEK293 and HeLa cell lines were kindly provided by Dr.
Breda Twomey (UCB Pharma, UK) and the Chinese ham-
ster ovary (CHO) cell line was a generous gift from Dr.
Pamela Reynolds (MRC, Harwell, UK). 35 mm glass bottom
dishes were purchased from MatTech Corporation, USA.
HEK293 and HeLa cells were cultured in Eagle’s min-
imal essential medium (EMEM) (ATCC) containing 10%
Foetal calf serum (FCS) and supplemented with 100 units/
mL penicillin G sodium and 100 mg/mL streptomycin.
CHO cells were cultured in DMEM/F12 supplemented
with 10% FCS (Sigma) 50 units/mL penicillin G sodium,
50 mg/mL streptomycin, 2 mM L-glutamine (Invitrogen)
at 37°C with 5% CO2 humidified air. Cells were either
washed with x1 phosphate buffered saline (PBS) or main-
tained in full media prior to multiphoton confocal
microscopy.
Construction of EGFP-Rheb and DsRed-Rheb
The following reagents were obtained commercially: re-
striction enzymes (NEB), TOPO vector (Invitrogen), Mini-
prep and Midiprep kit (QIAGEN) and a Ligation kit
(NEB). The Rheb cDNA clone contained in a pOTB7 vec-
tor (Gene service, IMAGE ID 3528583) and was PCR
amplified using the forward primer containing EcoRI and
the reverse primer containing the SalI restriction enzyme
site to clone EGFP at the N-terminus of Rheb. Also,
pDsRedN1was PCR amplified using the forward primers
containing AgeI and the reverse primer containing BspeI
restriction enzyme site using pDsRedN1 as a template to
create pDsRedC1 vector (Table 1). To clone EGFP at the
N-terminus of Rheb, EcoRI and SalI were used to digest a
Rheb DNA fragment from the TOPO clone which was
then gel purified and subcloned into EcoRI and SalI sites
of pEGFP-C1 to create EGFP-Rheb. To generate a
DsRedC1 vector from DsRedN1, AgeI and BspeI were
used to digest DsRedN1 DNA fragment from the TOPO
Yadav et al. BMC Cell Biology 2013, 14:3 Page 13 of 16
http://www.biomedcentral.com/1471-2121/14/3clone which was subcloned into the AgeI and BspeI sites
of pEGFPC1 to obtain DsRedC1. One positive clone was
selected for further subcloning of DsRed-Rheb. The EcoRI
and SalI cut Rheb DNA fragments from the TOPO clone
was subcloned into EcoRI and SalI sites of newly gener-
ated DsRedC1 to produce DsRedC1-Rheb.
Construction of EGFP cloned to the C- and N-terminus of
mTOR
The N-terminal tagged (EGFP-mTOR) and C-terminal
tagged (mTOR-EGFP) vectors were constructed using
mTOR cDNA contained in a pCMV6-XL4 vector. The
cloning strategy to tag EGFP at the N and C-terminus of
mTOR involved insertion of HindIII and SalI restriction
enzyme sites on both ends of mTOR using PCR amplifi-
cation of the entire fragment of mTOR DNA. The Fer-
menta’s Long PCR Enzyme Mix (Ferments, UK) was
used for PCR amplification with high fidelity DNA poly-
merase with proof-reading activity. The PCR amplifica-
tion was performed by designing 4 primers (2 for each
cloning) using the mTOR-pCMV6-XL4 vector as a tem-
plate (Table 2). The cloning strategy involved three sub-
cloning steps; the PCR product (7.6 Kb) (for EGFP-
mTOR and mTOR-EGFP) was cloned into the PCR II
TOPO vector and both ends of the amplified fragments
sequenced, the DNA fragment from the original mTOR
DNA fragment of the pCMV6-XL4 vector was replaced
using NheI and BspEI restriction enzyme sites and the
digested TOPO vector cloned into the HindIII and SalI
sites of pEGFPC1 and pEGFPN1. Restriction digestion
analysis, sequencing and Western blotting confirmed
that the fluorescently cloned proteins were correct.
Construction of the DsRed-Raptor vector
The DsRed fluorescent protein was tagged to the N-
terminal of raptor to construct a DsRed-Raptor vector.
The DsRed-Raptor construct was generated from the
haemagglutinin (HA) tagged raptor contained in a pRK5
expression vector. The cloning strategy to generate the
DsRed-Raptor construct involved PCR amplification of a
DsRed-PCRII TOPO vector (generated as above for
DsRedC1 cloning) using the forward primer containing
EcoRI and the reverse primer containing a SalI restric-
tion enzyme site (Table 3). The gel purified PCR product
of DsRed was subcloned into a PCR-II TOPO vector.





DsRed(m)_BspeI_RPthe TOPO clone was gel purified and subcloned into
EcoRI and SalI sites of a pRK5 expression vector con-
taining raptor to generate a DsRed-Raptor vector.
Confirmation of fluorescently tagged Rheb, raptor and
mTOR Proteins
Gel purified PCR products of Rheb and DsRed were sub-
cloned into PCR-II TOPO vector (TA). The PCR pro-
ducts in TOPO vector were confirmed by restriction
digestion analysis and sequencing (Gene service, Ox-
ford). The restriction analysis of EGFP-Rheb and DsRed-
Rheb was carried out by AgeI restriction enzyme. Simi-
larly cloning of DsRed-raptor vector was confirmed by
restriction analysis by EcoRI and SalI restriction enzyme.
The two mTOR constructs, EGFP-mTOR in which
EGFP is tagged to the N-terminal of mTOR and mTOR-
EGFP which contains EGFP at the C-terminal of mTOR
were made. Initially the PCR product amplified for the
cloning was confirmed for the correct sequence by clon-
ing the PCR product in to PCR-II-TOPO vector, the
cloning was verified by restriction digestion analysis and
sequencing of both ends of PCR products. Using the
correct clones, the middle fragment of PCR product in
TOPO vector was replaced with a DNA fragment from
the original mTOR vector following cutting of the whole
fragment of mTOR from TOPO vector using HindIII
and SalI restriction enzyme sites and then cloned into
pEGFPC1 and pEGFPN1 vector to get N-terminal and
C-terminal tagged EGFP of the mTOR respectively.
These final constructs were confirmed by restriction en-
zyme digestion by BamHI (see Tables 1, 2, 3 for primer
details).
Rheb undergoes post-translational lipid modification by
farnesylation at its C-terminal CAAX motif. Farnesylation
is important for Rheb localization to endomembrane and
activation of the mTOR pathway. Thus, to avoid any
changes at the C-terminus of Rheb, EGFP and DsRed were
located at the N-terminus of Rheb. In our current studies,
the rather large and difficult mTOR has been successfully
tagged with EGFP at either terminus and discussed below.
Immunoblots of EGFP-Rheb, EGFP-mTOR and DsRed-
raptor and an antibody to phosphorylated S6-kinase in
HEK293 cells
Following 24 h or 48 h of transfection, HEK293 cells were
detached by trypsinization and collected by centrifugation.-Rheb and DsRed-Rheb (5' – 3' direction; restriction sites
TGA ATTC GC CGC AGT CCA AGT CCC GG
GGG GTC GAC TCA CAT CAC CGA GCA TGA AGA C
AAC CGG TCG CCA CCA TGG AC
GGT CCG GA C TGG GAG CCG GAG TGG CG
Table 2 Primers used for PCR amplification to construct EGFP-mTOR and mTOR-EGFP (5' – 3' direction; restriction sites
underlined)
1_HindIII_FP GGG AAA TAC GTA AAG CTT AAG ATG GGG CTT GGA ACC GG
4_SalI_RP GGG CGG CCG CGT CGA CCC CCA GAA AGG GCA CCA GC
5_HindIII_FP GGG AAA TAC GTA AAG CTT TAC TTG GAA CCG GAC CTG C
8_SalI_RP GGG GTC GAC TTA CCA GAA AGG GCA CCA GC
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HCl pH 7.5, 350 mM NaCl, 1mM MgCl2), 0.5 mMEDTA,
1 mM EGTA, with protease inhibitor cocktail (Sigma) and
NP40 1%) and lysates were subjected to Western blot ana-
lysis using specific antibodies to Rheb (Santa Cruz Bio-
technology), and mTOR, raptor and phosphorylated S6-
kinase (thr389) (Cell Signalling Technology, Inc.) as well
as GAPDH to ensure loading onto gel lanes was the same.
The data show that all three constructs were expressed,
that they did not affect the level of endogenous/expressed
levels of each other. The functionality of each of the
tagged constructs was examined by probing the gels with
an antibody to phosphorylated S6-kinase.Cell transfection
2x105 cells were plated in 35 mm glass bottom dishes for
24h. Cells were transiently transfected with 0.5 μg of DNA
using Fugene HD (Roche, UK) transfection reagent. Cells
were then examined after 24-48h of transfection.
Exponentially-growing cells were imaged under confocal
and multiphoton excitation microscopy.Immunohistochemical staining
Cells were grown on 35 mm glass-bottom dishes at 2x105
cells/dish and transfected with EGFP-Rheb for 24h. Fol-
lowing the transfection period the cells were fixed for 30
min with 4% (v/v) paraformaldehyde in PBS warmed to
37°C. Cells were washed three time and permeabilised
with 0.2% Triton X-100 in PBS for 10 min followed by a
further three washes with PBS. The cells were blocked for
one hour in blocking buffer (1% BSA in PBS) and incu-
bated with primary antibody (Rheb (C-19), Santa Cruz
Biotech) in blocking buffer for 1h at room temperature,
rinsed three times with PBS and incubated with fluores-
cently labelled secondary antibody (donkey anti-goat IgG-
TR:sc-2783, Santa Cruz Biotech) (diluted in blocking buf-
fer 1:200) for 1h at room temperature in the dark. The
cells were then imaged with a Nikon TE2000U inverted
microscope attached to a confocal microscope (see below
for details).Table 3 Primers used for PCR amplification to construct DsRe
DsRed(m)_EcoRI_FP
DsRed(m)_SalI_RPCo-localization stains
EGFP-Rheb transfected HEK293 and HeLa cells were
stained with BODIPY TR C5 ceramide, ER Tracker Red
(BODIPY TR glibenclamide) and Mitotracker red (all
from Molecular Probes, Invitrogen) for live cell imaging.
For Golgi staining, cells were washed twice with Hank's
Buffered Salt Solution (HBSS), 5 μM BODIPY TR C5 cer-
amide in HBSS was then added and the cells incubated at
4°C for 30 min. Samples were washed several times with
ice cold medium and incubated in fresh medium for 30
min at 37°C before processing for imaging. For ER
Tracker staining pre-warmed HBSS with 1μM ER Tracker
red stain was added to cells for 30 min at 37°C. For Mito-
tracker red staining, cells were incubated with Optimem
reduced serum medium containing 100 nM of Mito-
tracker red stain for 30 min at 37°C. The staining solution
was removed and the cells rinsed once with 1 ml of warm
PBS prior to addition of 2 ml of pre-warmed fresh growth
medium.
Amino acid starvation
Serum starvation and amino acid re-stimulation experi-
ments were performed by plating the cells into glass bot-
tom dishes and transfected, as described above, followed
by incubation for 24h. Cells were washed in PBS and
maintained in culture medium containing penicillin/
streptomycin and L-glutamine without FCS at 37°C and
5% CO2 in humidified air overnight (16-18h) until ana-
lysis. During amino acid starvation experiments, cells
were washed once with 2 mL of warm (37°C) D-PBS.
Followed by addition of 2ml of D-PBS and incubated at
37°C and 5% CO2 in humidified air for 1h. Amino acid-
starved cells were stimulated using either 50x amino
acid mixture (Sigma Aldrich, UK) or 10x amino acid
mixture.
Confocal and two-photon induced fluorescence time-
correlated single photon counting image data acquisition
Confocal and multiphoton images of the fluorescent pro-
tein expression were collected using an inverted Nikon
TE2000-U microscope attached to a Nikon C1 scanningd-Raptor (5' – 3' direction; restriction sites underlined)
GGA ATT CAT GGA CAA CAC CGA GGA CG
GGG GTC GAC CCC TGG GAG CCG GAG TGG CGG G
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excitation) filter set. Cells were selected for analysis on the
basis of equal expression for all the protein constructs to
ensure comparability between different interactions. All
images were obtained using a 60× water immersion ob-
jective with a N.A. of 1.2. The data/images from the red
and green channels were used to confirm at least an equal
expression (or excess of the red fluorescence) prior to
FLIM data collection. Fluorescence lifetime images were
obtained using a two-photon-microscopy apparatus,
which has an external x, y galvanometer scanning system
(GSI Lumonics) {18}. Laser light at a wavelength of 920 ±
5 nm was obtained from a titanium sapphire laser (Mira,
Coherent) producing 180 fs pulses at 75 MHz pumped by
a frequency doubled vanadate laser (Coherent Lasers).
Fluorescence emission was collected without descanning,
by-passing the scanning system, and passed through a
bandpass filter (BG39, Comar). The scan was operated in
the normal mode and line, frame and pixel clock signals
were generated and synchronized with an external fast
micro-channel plate photomultiplier tube (Hamamatsu
R3809U) used as the detector. These were linked via a
time-correlated single photon counting (time-correlated
single photon counting) TCSPC PC module SPC830
(Becker and Hickl). The set up provided instrument quan-
tum efficiencies of more than 50% with single photon de-
tection capabilities. The non-descan method also allows
increased signal detection over the one-photon method.
Data of in vitro one and two photon fluorescence and
emission lifetime studies of these TCSPC lifetime imaging
micrographs were analysed using SPC Image analysis soft-
ware (Becker and Hickl, Germany). The lifetime distri-
bution histograms presented are determined from
calculations at each pixel in the FLIM image at each indi-
vidual single pixel x, y such that I (ti, xj, yj) is the fluores-
cence intensity at time ti in pixel xyj. The decay must be
convolved with the instrumental response function (IRF).
Thus each recording of the fluorescence decay in a pixel
can be considered as a separate experiment. The accuracy
of the decay fitting is characterized by a χ2 close to 1. We
have determined our instrument response function to be
50 ± 10 ps, so that this can be ignored in our data analysis
since the changes we report (>100 ps) are significantly lar-
ger. The quoted lifetime values are derived from summing
up and averaging all the pixel values (generally 128 x 128)
i.e. 16348 individual values to derive the pictorial histo-
gram and associated error bars from this and the repeat of
at least 3 independent experiments.Abbreviations
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